Literature DB >> 16251405

Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis.

Jennifer L Faulkner1, Lisa M Szcykalski, Fredyne Springer, Jeffrey L Barnes.   

Abstract

To determine whether previous renal injury accelerates the progression of glomerulosclerosis and interstitial fibrosis, we examined the effect of treating rats with angiotensin II after Habu venom injury. After initiating disease, we examined the origin of interstitial myofibroblasts by locating alpha-smooth muscle actin (alpha-SMA)-positive and Na+,K+-ATPase-positive cells relative to interstitial space, tubular epithelial cells, the tubular basement membrane (TBM), and vascular structures. Tubular epithelial-mesenchymal transition was also assessed by examining TBM integrity and by using Texas Red (TR)-dextran in intravital tracking experiments. The staining of alpha-SMA-positive myofibroblasts dramatically increased in peritubular interstitial spaces 48 hours after Habu venom plus angiotensin II, particularly in and around perivascular and periglomerular regions, while tubular epithelial cells were alpha-SMA-negative. Na+,K+-ATPase-positive and TR-dextran-labeled cells were restricted to the tubular epithelium and excluded from the interstitium. By 7 and 14 days, expanded interstitial space contained only alpha-SMA-positive myofibroblasts without TR-dextran endocytic particles. Epithelium of atrophic tubules containing TR-dextran remained confined by surrounding interstitium and myofibroblasts. These studies indicate that early expansion of alpha-SMA-positive cells in the interstitium and loss of tubular area occur via encroachment of interstitial myofibroblasts from perivascular into atrophic tubular spaces rather than via epithelial-mesenchymal transition and migration of tubular cells through the TBM into the interstitium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251405      PMCID: PMC1603794          DOI: 10.1016/S0002-9440(10)61208-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

Review 1.  The activated mesangial cell: a glomerular "myofibroblast"?

Authors:  R J Johnson; J Floege; A Yoshimura; H Iida; W G Couser; C E Alpers
Journal:  J Am Soc Nephrol       Date:  1992-04       Impact factor: 10.121

2.  A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats.

Authors:  T Shimamura; A B Morrison
Journal:  Am J Pathol       Date:  1975-04       Impact factor: 4.307

3.  Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease.

Authors:  R Wiggins; M Goyal; S Merritt; P D Killen
Journal:  Lab Invest       Date:  1993-05       Impact factor: 5.662

4.  Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis.

Authors:  T Yamamoto; N A Noble; D E Miller; W A Border
Journal:  Kidney Int       Date:  1994-03       Impact factor: 10.612

5.  Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms.

Authors:  R Tanaka; V Kon; T Yoshioka; I Ichikawa; A Fogo
Journal:  Kidney Int       Date:  1994-02       Impact factor: 10.612

6.  Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis.

Authors:  C M Giachelli; R Pichler; D Lombardi; D T Denhardt; C E Alpers; S M Schwartz; R J Johnson
Journal:  Kidney Int       Date:  1994-02       Impact factor: 10.612

7.  Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis.

Authors:  J L Barnes; H E Abboud
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

8.  Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy.

Authors:  D C Cattran; C Greenwood; S Ritchie
Journal:  Am J Kidney Dis       Date:  1994-02       Impact factor: 8.860

9.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

Authors:  E J Lewis; L G Hunsicker; R P Bain; R D Rohde
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

Review 10.  Angiotensin II as a renal growth factor.

Authors:  G Wolf; E G Neilson
Journal:  J Am Soc Nephrol       Date:  1993-03       Impact factor: 10.121

View more
  50 in total

1.  mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.

Authors:  Stéphanie Eid; Suzan Boutary; Kawthar Braych; Ramzi Sabra; Charbel Massaad; Ahmed Hamdy; Awad Rashid; Sarah Moodad; Karen Block; Yves Gorin; Hanna E Abboud; Assaad A Eid
Journal:  Antioxid Redox Signal       Date:  2016-09-12       Impact factor: 8.401

2.  Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy.

Authors:  Masumi Kamiyama; Masaaki Kobayashi; Shin-ichi Araki; Aritoshi Iida; Tatsuhiko Tsunoda; Koichi Kawai; Masahito Imanishi; Makoto Nomura; Tetsuya Babazono; Yasuhiko Iwamoto; Atsunori Kashiwagi; Kohei Kaku; Ryuzou Kawamori; Daniel P K Ng; Torben Hansen; Peter Gaede; Oluf Pedersen; Yusuke Nakamura; Shiro Maeda
Journal:  Hum Genet       Date:  2007-08-02       Impact factor: 4.132

Review 3.  Stem cells in airway smooth muscle: state of the art.

Authors:  Jaime Murphy; Ross Summer; Alan Fine
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

4.  Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis.

Authors:  Mizuho Yamada; Kazuyoshi Kuwano; Takashige Maeyama; Naoki Hamada; Michihiro Yoshimi; Yoichi Nakanishi; Michael Kasper
Journal:  Histochem Cell Biol       Date:  2008-01-31       Impact factor: 4.304

5.  The origin of renal fibroblasts and progression of kidney disease.

Authors:  H Terence Cook
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

6.  Altered expression of hepatic β-adrenergic receptors in aging rats: implications for age-related metabolic dysfunction in liver.

Authors:  Yun Shi; Zhen-Ju Shu; Hanzhou Wang; Jeffrey L Barnes; Chih-Ko Yeh; Paramita M Ghosh; Michael S Katz; Amrita Kamat
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-12-06       Impact factor: 3.619

7.  Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin.

Authors:  Kavithalakshmi Sataranatarajan; Meenalakshmi M Mariappan; Myung Ja Lee; Denis Feliers; Goutam Ghosh Choudhury; Jeffrey L Barnes; Balakuntalam S Kasinath
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

8.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.

Authors:  Benjamin D Humphreys; Shuei-Liong Lin; Akio Kobayashi; Thomas E Hudson; Brian T Nowlin; Joseph V Bonventre; M Todd Valerius; Andrew P McMahon; Jeremy S Duffield
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

9.  Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor.

Authors:  Sho Ishizawa; Junko Takahashi-Fujigasaki; Yasushi Kanazawa; Keiichiro Matoba; Daiji Kawanami; Tamotsu Yokota; Takeo Iwamoto; Naoko Tajima; Yoshinobu Manome; Kazunori Utsunomiya
Journal:  Clin Exp Nephrol       Date:  2014-01-25       Impact factor: 2.801

10.  Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression?

Authors:  Eva A Turley; Mandana Veiseh; Derek C Radisky; Mina J Bissell
Journal:  Nat Clin Pract Oncol       Date:  2008-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.